GRI Bio, Inc.

GRI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jan 24, 2025 FORM 4
4 Jan 24, 2025 FORM 4
DEF 14A Jan 17, 2025 DEF 14A
PRE 14A Jan 7, 2025 PRE 14A
S-8 Jan 6, 2025 S-8
8-K Dec 20, 2024 8-K
424B5 Dec 20, 2024 424B5
EFFECT Nov 22, 2024
CORRESP Nov 20, 2024
UPLOAD Nov 20, 2024
424B3 Nov 15, 2024 424B3
S-3 Nov 14, 2024 S-3
8-K Nov 14, 2024 8-K
10-Q Nov 14, 2024 10-Q
D Oct 25, 2024
8-K Oct 24, 2024 8-K
8-K Oct 22, 2024 8-K
8-K/A Sep 11, 2024 8-K/A
424B3 Sep 11, 2024 424B3
424B3 Sep 11, 2024 424B3
8-K Sep 11, 2024 8-K
8-K Sep 6, 2024 8-K
424B3 Aug 28, 2024 424B3
424B3 Aug 28, 2024 424B3
424B3 Aug 28, 2024 424B3
← Newer Page 5 of 16 · 399 filings Older →